What is the recommended management for hypospadias, including optimal timing, surgical technique, pre‑operative testosterone use, postoperative care, and follow‑up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Hypospadias

Surgical repair should be performed between 6-18 months of age, with preoperative testosterone reserved specifically for proximal hypospadias with small glans diameter (<14 mm), and staged procedures increasingly preferred for severe cases to minimize complications and optimize long-term functional outcomes. 1

Preoperative Counseling and Assessment

Comprehensive caregiver counseling is essential before proceeding with surgical management. The primary goals are achieving normal penile function and appearance by addressing the proximal meatus, meatal stenosis, ventral curvature, and preputial deformity 1.

Assessment of Penile Curvature

  • Curvature >30° typically warrants correction 1
  • Penile curvature correlates directly with hypospadias severity
  • Evaluation involves assessment during artificial erection to determine degree and direction of deviation

Preoperative Testosterone Therapy

Indications (Selective Use Only)

Evidence for preoperative hormone therapy remains equivocal, and hormonal treatment should be limited to patients with proximal hypospadias with small glans diameter 1. The 2025 EAU-ESPU guidelines emphasize this selective approach rather than routine use.

When to Consider Testosterone:

  • Proximal hypospadias with glans diameter <14 mm 1
  • Small penile dimensions requiring tissue augmentation
  • Cases anticipated to have technical surgical difficulty

Dosing Regimens:

  • Intramuscular testosterone enanthate: 2 mg/kg administered 5 and 2 weeks before surgery 2
  • Alternative: 25 mg monthly for 2-3 months preoperatively 3
  • The first dose produces the most significant effect—consider stopping therapy once adequate response is achieved 4

Important Caveats About Testosterone Use:

The evidence shows conflicting results regarding complications. While testosterone increases glans diameter and stretched penile length significantly 2, 5, it also causes:

  • Increased intraoperative hemorrhage requiring tourniquet placement (44.4% vs 26.1% in controls) 4
  • Decreased glans-to-corpus ratio, potentially complicating glanuloplasty 4
  • Transient side effects in 72.2% of patients (mostly mild, but 27.8% experience severe effects including thick pubic hair growth, frequent erections, or penile hypersensitivity) 4

Critical finding: Recent evidence shows no increased urethrocutaneous fistula risk with preoperative testosterone (7.3% vs 7.1%, p=0.357), suggesting improved tissue bulk and vascularity may offset inflammatory changes 2. Long-term outcomes (penile length, height, cosmesis) show no difference between testosterone-treated and non-treated patients 6.

Timing Consideration:

Delaying surgery >3 months after completing androgen treatment may circumvent androgen-induced vascularity and poor wound healing 5. Serial measurements demonstrate sustained glans width increases persist >1 year post-treatment 5.

Surgical Timing

Primary hypospadias repair should occur at 6-18 months of age 1. This timing balances:

  • Adequate tissue size for reconstruction
  • Minimizing psychological impact
  • Optimal wound healing capacity

Surgical Technique Selection

For Curvature Correction:

In severe hypospadias, urethral plate mobilization without transection is NOT recommended due to high risk of ventral curvature recurrence (20%) and stricture formation (17%) 1.

Technique Options:

  • Dorsoplication with or without tunica albuginea excision
  • Ventral lengthening via corporotomy techniques with or without grafting

For severe curvature, ventral lengthening is superior to dorsoplication (curvature recurrence: 5% vs 25%) 1.

Critical Technical Restriction:

Tubularized incised plate (TIP) procedure should ONLY be performed when curvature is <30° 1. TIP for proximal hypospadias carries a high ventral curvature recurrence rate (26%) 1.

One-Stage vs Staged Procedures:

Staged procedures are increasingly preferred due to:

  • Lower recurrence rate for ventral curvature
  • Better overall outcomes
  • Though long-term complication rates vary 1

Essential Technical Considerations:

Second-layer coverage of the neourethra minimizes fistula incidence 1. This is a critical technical step that should not be omitted.

Postoperative Care

Stents and Dressings:

  • No consensus exists on optimal duration for stents and dressings 1
  • The type of stent material or dressing does NOT impact surgical outcomes 1

Prophylactic Antibiotics:

Prophylactic antibiotics in distal hypospadias repair do NOT reduce postoperative surgical site infection or UTI rates 1. Therefore, routine prophylactic antibiotics are not recommended for distal repairs.

Preputial Reconstruction:

Can be considered if foreskin is not required for reconstruction:

  • No change in urethral complication risk 1
  • Moderate risk of preputial dehiscence (7-17%) 1
  • Secondary phimosis risk (1.5%) 1

Expected Outcomes and Complications

Success Rates:

  • Distal hypospadias: 85-90% successful primary repair 1
  • Proximal hypospadias: 32-86% successful primary repair 1
  • Complications occur in 23.3% of repeat repairs vs 12.2% of primary repairs 1

Common Complications:

Urethrocutaneous fistula: 5-50% overall 1

  • Wide range reflects severity variation and technique differences

Meatal stenosis: 5-15% of cases 1

  • Inlay grafts reduce meatal stenosis risk by 66% 1—consider this technique when appropriate

Urethral strictures: 8-13% 1

  • More common in proximal repairs, even with staged procedures

Glans dehiscence: 9-17% 1

  • Linked to smaller glans (<14 mm) and proximal hypospadias
  • Rarely impacts long-term function despite aesthetic concerns

Long-Term Follow-Up

Long-term follow-up after hypospadias repair is essential 1. Recent data shows:

  • Total reoperation rate of 48% in first 15 years of life for proximal hypospadias 1
  • Significant rates of late complications have been reported 1
  • Obstructive urinary flow patterns can develop

This high reoperation rate for proximal cases underscores the importance of:

  • Careful initial surgical planning
  • Appropriate technique selection
  • Extended surveillance into adolescence and young adulthood

Key Clinical Pitfalls to Avoid

  1. Do not use TIP procedure for curvature ≥30°—this significantly increases complication rates
  2. Do not mobilize urethral plate without transection in severe hypospadias—20% curvature recurrence risk
  3. Do not routinely use testosterone—reserve for proximal cases with small glans only
  4. Do not skip second-layer neourethral coverage—critical for fistula prevention
  5. Do not assume single-stage repair is always optimal—staged procedures often yield better outcomes in complex cases
  6. Do not neglect long-term follow-up—nearly half of proximal cases require reoperation within 15 years

References

Related Questions

What is the recommended management for a 6‑ to 12‑month‑old infant with hypospadias, including timing of surgery, choice of repair technique based on lesion location, use of pre‑operative testosterone, and postoperative care?
How does a bilateral hydrocele affect testosterone levels in adult males?
Can hormonal therapy or surgical procedures increase penile size in an adult who has previously undergone hypospadias repair?
For a 32‑year‑old woman with depressive symptoms and a maternal history of bipolar I disorder, which antipsychotic is effective for both bipolar depression and mania?
Is magnesium citrate appropriate for use as a sleep aid in a patient with normal renal function (creatinine clearance ≥ 20 mL/min) and no history of hypermagnesemia?
What is the recommended duration of antimicrobial therapy for enteroinvasive Escherichia coli infection?
In a 32‑year‑old woman with a family history of bipolar I who appears to have bipolar II, would lurasidone (Latuda) be an appropriate treatment and could it prevent hypomanic or manic episodes?
What are the possible medical and psychiatric causes of anxiety in a patient presenting with restlessness, insomnia, panic‑type breathing difficulty, irritability, loss of appetite, diarrhea, nasal congestion, and a sensation of insects crawling on the skin?
What are examples of non‑invasive ventilation (NIV) modalities, and is non‑invasive ventilation safer than high‑flow nasal cannula (HFNC) in a patient at high risk of aspiration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.